Cosmo & Ferring Pharmaceuticals enter into licensing agreement for CORTIMENT®MMX® (budesonide) in Japan
-Cosmo Pharmaceuticals S.A. (SIX: COPN) announced today that it has signed a licensing agreement with Ferring Pharmaceuticals…
Ferring Pharmaceuticals submits variation application to introduce new tailored dosing regimen in the PICOPREP® (sodium picosulfate, magnesium oxide, citric acid) label
-Ferring Pharmaceuticals announced today that it has submitted a variation application in the Mutual Recognition…
Ferring receives acceptance of Marketing Authorisation filing from EMA for personalised fertility treatment with REKOVELLE® (follitropin delta)
-Ferring Pharmaceuticals announced today that the filing for the Marketing Authorisation Application for…
Ferring Pharmaceuticals acquires global rights to MILPROSA (progesterone vaginal ring)
-Ferring Pharmaceuticals announced today that it has acquired the global rights to MILPROSATM (progesterone vaginal ring) from Teva Women’s…
Ferring Pharmaceuticals begins Phase 2b/3 trial of selepressin for treatment of septic shock
-Ferring Pharmaceuticals announced initiation of patient enrollment in a phase 2b/3 clinical trial of selepressin for the treatment of septic shock…
Archives Press release 2015
Archives Press release 2015